跳至主要内容
临床试验/NCT04463940
NCT04463940Unknown不适用

The Origin of Xanthine Oxidase and Its Metabolite, Uric Acid, in Preeclamptic Pregnant Women - A Pilot Study

Barzilai Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年6月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Uric Acid

研究概览

简要总结

Findings regarding the presence of xanthine oxidase and uric acid in different blood locations is important in preeclamptic women. We aim to detecting Xanthine oxidase and uric acid levels in both umbilical cord artery and vein as well as maternal blood (3 "locations") in pregnant women with and without diagnosis of preeclampsia. The study population will be divided into groups matching the three "locations" in order to describe and compare outcome levels.

详细描述

Significance - findings regarding the presence of xanthine oxidase and uric acid in different blood locations may provide a scientific basis for understanding the source of them in preeclamptic women. Aim - detecting Xanthine oxidase and uric acid levels in both umbilical cord artery and vein as well as maternal blood (3 "locations"). Methods - samples will be collected from pregnant women with and without diagnosis of preeclampsia with blood uric acid > 6 mg/dL. Than the study population will be divided into groups matching the three "locations". The investigators will describe and compare outcome levels (including Xanthine oxidase, uric acid).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • preeclampsia and none-preeclampsia diagnosed pregnant women.

排除标准

  • Known or reported kidney disease.

结局指标

主要结局

Uric Acid

时间窗: through study completion, an average of 1 year

mg/dL

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Simon Shanhav

Dr Simon Shenhav, head of High Risk Pregnancy Unit

Barzilai Medical Center

研究点 (1)

Loading locations...

相似试验